Iroquois homeobox transcription factor (Irx5) promotes G1/S-phase transition in vascular smooth muscle cells by CDK2-dependent activation
Open Access
- 1 August 2016
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 311 (2) , C179-C189
Abstract
The Iroquois homeobox ( Irx5) gene is essential in embryonic development and cardiac electrophysiology. Although recent studies have reported that IRX5 protein is involved in regulation of the cell cycle and apoptosis in prostate cancer cells, little is known about the role of IRX5 in the adult vasculature. Here we report novel observations on the role of IRX5 in adult vascular smooth muscle cells (VSMCs) during proliferation in vitro and in vivo. Comparative studies using primary human endothelial cells, VSMCs, and intact carotid arteries to determine relative expression of Irx5 in the peripheral vasculature demonstrate significantly higher expression in VSMCs. Sprague-Dawley rat carotid arteries were subjected to balloon catherization, and the presence of IRX5 was examined by immunohistochemistry after 2 wk. Results indicate markedly elevated IRX5 signal at 14 days compared with uninjured controls. Total RNA was isolated from injured and uninjured arteries, and Irx5 expression was measured by RT-PCR. Results demonstrate a significant increase in Irx5 expression at 3–14 days postinjury compared with controls. Irx5 genetic gain- and loss-of-function studies using thymidine and 5-bromo-2′-deoxyuridine incorporation assays resulted in modulation of DNA synthesis in primary rat aortic VSMCs. Quantitative RT-PCR results revealed modulation of cyclin-dependent kinase inhibitor 1B ( p27 kip1), E2F transcription factor 1 ( E2f1), and proliferating cell nuclear antigen ( Pcna) expression in Irx5-transduced VSMCs compared with controls. Subsequently, apoptosis was observed and confirmed by morphological observation, caspase-3 cleavage, and enzymatic activation compared with control conditions. Taken together, these results indicate that Irx5 plays an important role in VSMC G1/S-phase cell cycle checkpoint control and apoptosis.Keywords
Funding Information
- HHS | NIH | National Heart, Lung, and Blood Institute (NHBLI) (K01 HL084760-01, 5R25 HL003676, 1P50 HL117929)
- HHS | NIH | National Center on Minority Health and Health Disparities (NCMHD) (8G12 MD007602)
This publication has 44 references indexed in Scilit:
- Interaction between transcription factors Iroquois proteins 4 and 5 controls cardiac potassium channel Kv4.2 gene transcriptionCardiovascular Research, 2008
- The Iroquois Homeobox Gene 5 Is Regulated by 1,25-Dihydroxyvitamin D3 in Human Prostate Cancer and Regulates Apoptosis and the Cell Cycle in LNCaP Prostate Cancer CellsClinical Cancer Research, 2008
- Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2Cell, 2007
- Neuronal Chemorepellent Slit2 Inhibits Vascular Smooth Muscle Cell Migration by Suppressing Small GTPase Rac1 ActivationCirculation Research, 2006
- Regional variation in mRNA transcript abundance within the ventricular wallJournal of Molecular and Cellular Cardiology, 2006
- The Iroquois homeobox gene, Irx5, is required for retinal cone bipolar cell developmentDevelopmental Biology, 2005
- Cell cycle control by homeobox genes in development and diseaseSeminars in Cell & Developmental Biology, 2005
- TALE class homeodomain gene Irx5 is an immediate downstream target for Hoxb4 transcriptional regulationDevelopmental Dynamics, 2003
- Irx4 Forms an Inhibitory Complex with the Vitamin D and Retinoic X Receptors to Regulate Cardiac Chamber-specific slow MyHC3ExpressionJournal of Biological Chemistry, 2001
- Regulation of Chamber-Specific Gene Expression in the Developing Heart by Irx4Science, 1999